![Jamal El-Mosleh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jamal El-Mosleh
No open positions remaining
Profile
Jamal El-Mosleh was the founder of Elicera Therapeutics AB, founded in 2014, and served as Chief Executive Officer from 2014 to 2026.
Former jobs include Chief Executive Officer & IR Contact at Mendus AB from 2007 to 2016, Chief Executive Officer at Annexin Pharmaceuticals AB from 2017 to 2019, and Director at Elypta AB from 2016 to 2020.
Education history includes graduation from Chalmers University of Technology and graduation from Chalmers School of Entrepreneurship in 2006.
Former positions of Jamal El-Mosleh
| Companies | Position | End |
|---|---|---|
| ELICERA THERAPEUTICS AB | Chief Executive Officer | 01/09/2026 |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Director/Board Member | 01/01/2020 |
| ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | 01/01/2019 |
| MENDUS AB | Chief Executive Officer | 01/10/2016 |
Training of Jamal El-Mosleh
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Chalmers University of Technology
 Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
 Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Chalmers School of Entrepreneurship
 Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annexin Pharmaceuticals AB
 Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Elicera Therapeutics AB
 Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
- Stock Market
- Insiders
- Jamal El-Mosleh
